Premier Biomedical, Inc.
BIEI
$0.0006
$0.000.00%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Revenue | 1.30K | 3.50K | 3.80K | 5.70K | 9.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.30K | 3.50K | 3.80K | 5.70K | 9.10K |
| Cost of Revenue | 7.40K | 1.70K | 1.80K | 2.10K | 93.20K |
| Gross Profit | -6.10K | 1.80K | 2.00K | 3.70K | -84.10K |
| SG&A Expenses | 101.00K | 66.40K | 75.00K | 85.90K | 378.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 108.40K | 68.00K | 76.70K | 87.90K | 471.20K |
| Operating Income | -107.00K | -64.60K | -72.90K | -82.20K | -462.10K |
| Income Before Tax | -34.30K | -181.60K | -227.00K | 68.50K | -501.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.30K | -181.60K | -227.00K | 68.50K | -501.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.30K | -181.60K | -227.00K | 68.50K | -501.70K |
| EBIT | -107.00K | -64.60K | -72.90K | -82.20K | -462.10K |
| EBITDA | -106.40K | -63.80K | -72.20K | -81.50K | -461.60K |
| EPS Basic | 0.00 | -0.01 | -0.02 | 0.01 | -0.10 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.01 | -0.07 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | 0.01 | -0.10 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.01 | -0.07 |
| Average Basic Shares Outstanding | 165.10M | 26.82M | 10.19M | 7.29M | 4.85M |
| Average Diluted Shares Outstanding | 165.10M | 26.82M | 10.19M | 7.29M | 4.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
